1. Vale, W., Spiess, J., Rivier, C. & Rivier, J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213, 1394–1397. https://doi.org/10.1126/science.6267699 (1981).
2. Kim, J. et al. Rapid, biphasic CRF neuronal responses encode positive and negative valence. Nat. Neurosci. 22, 576–585. https:// doi.org/10.1038/s41593-019-0342-2 (2019).
3. Kiss, J. Z., Mezey, E. & Skirboll, L. Corticotropin-releasing factor-immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy. Proc. Natl. Acad. Sci. U.S.A. 81, 1854–1858. https://doi.org/10.1073/pnas.81.6.1854 (1984).
4. Sawchenko, P. E., Swanson, L. W. & Vale, W. W. Co-expression of corticotropin-releasing factor and vasopressin immunoreactiv- ity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc. Natl. Acad. Sci. U.S.A. 81, 1883–1887. https://doi. org/10.1073/pnas.81.6.1883 (1984).
5. Itoi, K. et al. Suppression by glucocorticoid of the immunoreactivity of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of rat hypothalamus. Neurosci. Lett. 73, 231–236. https://doi.org/10.1016/0304-3940(87)90250-3 (1987).
6. Sawchenko, P. E., Swanson, L. W. & Vale, W. W. Corticotropin-releasing factor: co-expression within distinct subsets of oxytocin-, vasopressin-, and neurotensin-immunoreactive neurons in the hypothalamus of the male rat. J. Neurosci. 4, 1118–1129. https:// doi.org/10.1523/JNEUROSCI.04-04-01118.1984 (1984).
7. Ceccatelli, S., Eriksson, M. & Hökfelt, T. Distribution and coexistence of corticotropin-releasing factor-, neurotensin-, enkephalin-, cholecystokinin-, galanin- and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the parvocellular part of the paraventricular nucleus. Neuroendocrinology 49, 309–323. https://doi.org/10.1159/000125133 (1989).
8. Barakat, Y. et al. Immunocytochemical detection of cholecystokinin and corticotrophin-releasing hormone neuropeptides in the hypothalamic paraventricular nucleus of the jerboa (Jaculus orientalis): modulation by immobilisation stress. J. Neuroendocrinol. 18, 767–775. https://doi.org/10.1111/j.1365-2826.2006.01474.x (2006).
9. Dabrowska, J., Hazra, R., Guo, J.-D., Dewitt, S. & Rainnie, D. G. Central CRF neurons are not created equal: phenotypic differences in CRF-containing neurons of the rat paraventricular hypothalamus and the bed nucleus of the stria terminalis. Front. Neurosci. 7, 156–156. https://doi.org/10.3389/fnins.2013.00156 (2013).
10. Pacák, K. & Palkovits, M. S. Stressor specificity of central neuroendocrine responses: implications for stress-related disorders.Endocr. Rev. 22, 502–548. https://doi.org/10.1210/edrv.22.4.0436 (2001).
11. Biag, J. et al. Cyto- and chemoarchitecture of the hypothalamic paraventricular nucleus in the C57BL/6J male mouse: a study of immunostaining and multiple fluorescent tract tracing. J. Comp. Neurol. 520, 6–33. https://doi.org/10.1002/cne.22698 (2012).
12. Itoi, K., Jiang, Y. Q., Iwasaki, Y. & Watson, S. J. Regulatory mechanisms of corticotropin-releasing hormone and vasopressin gene expression in the hypothalamus. J. Neuroendocrinol. 16, 348–355. https://doi.org/10.1111/j.0953-8194.2004.01172.x (2004).
13. Wamsteeker Cusulin, J. I., Füzesi, T., Watts, A. G. & Bains, J. S. Characterization of corticotropin-releasing hormone neurons in the paraventricular nucleus of the hypothalamus of Crh-IRES-Cre mutant mice. PLoS ONE 8, e64943–e64943. https://doi.org/10.1371/ journal.pone.0064943 (2013).
14. Santoso, P., Maejima, Y., Kumamoto, K., Takenoshita, S. & Shimomura, K. Central action of ELABELA reduces food intake and activates arginine vasopressin and corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Neu- roReport 26, 820–826. https://doi.org/10.1097/WNR.0000000000000431 (2015).
15. Hu, P. et al. Gq protein-coupled membrane-initiated estrogen signaling rapidly excites corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus in female mice. Endocrinology 157, 3604–3620. https://doi.org/10.1210/en.2016-1191 (2016).
16. Yoshida, N. et al. Stressor-responsive central nesfatin-1 activates corticotropin-releasing hormone, noradrenaline and serotonin neurons and evokes hypothalamic-pituitary-adrenal axis. Aging (Albany NY) 2, 775–784. https://doi.org/10.18632/aging.100207 (2010).
17. Heisler, L. K. et al. Serotonin activates the hypothalamic–pituitary–adrenal axis via serotonin 2C receptor stimulation. J. Neurosci.27, 6956–6964. https://doi.org/10.1523/JNEUROSCI.2584-06.2007 (2007).
18. Horikawa, K. et al. Spontaneous network activity visualized by ultrasensitive Ca(2+) indicators, yellow Cameleon-Nano. Nat. Methods 7, 729–732. https://doi.org/10.1038/nmeth.1488 (2010).
19. Riegel, A. C. & Williams, J. T. CRF facilitates calcium release from intracellular stores in midbrain dopamine neurons. Neuron 57, 559–570. https://doi.org/10.1016/j.neuron.2007.12.029 (2008).
20. Brailoiu, G. C., Deliu, E., Tica, A. A., Chitravanshi, V. C. & Brailoiu, E. Urocortin 3 elevates cytosolic calcium in nucleus ambiguus neurons. J. Neurochem. 122, 1129–1136. https://doi.org/10.1111/j.1471-4159.2012.07869.x (2012).
21. Itoi, K. et al. Visualization of corticotropin-releasing factor neurons by fluorescent proteins in the mouse brain and characterization of labeled neurons in the paraventricular nucleus of the hypothalamus. Endocrinology 155, 4054–4060. https://doi.org/10.1210/ en.2014-1182 (2014).
22. Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neu- rosci. 13, 133–140. https://doi.org/10.1038/nn.2467 (2010).
23. Kono, J. et al. Distribution of corticotropin-releasing factor neurons in the mouse brain: a study using corticotropin-releasing factor-modified yellow fluorescent protein knock-in mouse. Brain Struct. Funct. 222, 1705–1732. https://doi.org/10.1007/s0042 9-016-1303-0 (2017).
24. Chen, Y., Molet, J., Gunn, B. G., Ressler, K. & Baram, T. Z. Diversity of reporter expression patterns in transgenic mouse lines targeting corticotropin-releasing hormone-expressing neurons. Endocrinology 156, 4769–4780. https://doi.org/10.1210/en.2015- 1673 (2015).
25. Paul, M., Poyan Mehr, A. & Kreutz, R. Physiology of local renin-angiotensin systems. Physiol. Rev. 86, 747–803. https://doi. org/10.1152/physrev.00036.2005 (2006).
26. Grobe, J. L., Xu, D. & Sigmund, C. D. An intracellular renin-angiotensin system in neurons: fact, hypothesis, or fantasy. Physiology (Bethesda) 23, 187–193. https://doi.org/10.1152/physiol.00002.2008 (2008).
27. Matsuda, T. et al. Distinct neural mechanisms for the control of thirst and salt appetite in the subfornical organ. Nat. Neurosci. 20, 230–241. https://doi.org/10.1038/nn.4463 (2017).
28. Hurt, R. C. et al. Angiotensin type 1a receptors on corticotropin-releasing factor neurons contribute to the expression of condi- tioned fear. Genes Brain Behav. 14, 526–533. https://doi.org/10.1111/gbb.12235 (2015).
29. Tian, Y. et al. Properties of AT1a and AT1b angiotensin receptors expressed in adrenocortical Y-1 cells. Am. J. Physiol. 270, E831– E839. https://doi.org/10.1152/ajpendo.1996.270.5.E831 (1996).
30. Haas, H. L., Sergeeva, O. A. & Selbach, O. Histamine in the nervous system. Physiol. Rev. 88, 1183–1241. https://doi.org/10.1152/ physrev.00043.2007 (2008).
31. Maintz, L. & Novak, N. Histamine and histamine intolerance. Am. J. Clin. Nutr. 85, 1185–1196. https://doi.org/10.1093/ ajcn/85.5.1185 (2007).
32. Thakkar, M. M. Histamine in the regulation of wakefulness. Sleep Med. Rev. 15, 65–74. https://doi.org/10.1016/j.smrv.2010.06.004 (2011).
33. Kjaer, A., Larsen, P., Knigge, U., Jorgensen, H. & Warberg, J. Neuronal histamine and expression of corticotropin-releasing hormone, vasopressin and oxytocin in the hypothalamus: relative importance of H1 and H2 receptors. Eur. J. Endocrinol. 139, 238–243. https://doi.org/10.1530/eje.0.1390238 (1998).
34. Maruko, T. et al. Involvement of the βγ subunits of G proteins in the cAMP response induced by stimulation of the histamine H1 receptor. Naunyn Schmiedebergs Arch. Pharmacol. 372, 153–159. https://doi.org/10.1007/s00210-005-0001-x (2005).
35. Picciotto, M. R., Higley, M. J. & Mineur, Y. S. Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron 76, 116–129. https://doi.org/10.1016/j.neuron.2012.08.036 (2012).
36. Xu, M. et al. Basal forebrain circuit for sleep-wake control. Nat. Neurosci. 18, 1641–1647. https://doi.org/10.1038/nn.4143 (2015).
37. Ohmori, N. et al. Effect of acetylcholine on corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats. Endocrinology 136, 4858–4863. https://doi.org/10.1210/endo.136.11.7588217 (1995).
38. Füzesi, T., Daviu, N., Wamsteeker Cusulin, J. I., Bonin, R. P. & Bains, J. S. Hypothalamic CRH neurons orchestrate complex behav- iours after stress. Nat. Commun. 7, 11937–11937. https://doi.org/10.1038/ncomms11937 (2016).
39. Saavedra, J. M. et al. Brain angiotensin II, an important stress hormone: regulatory sites and therapeutic opportunities. Ann. N. Y. Acad. Sci. 1018, 76–84. https://doi.org/10.1196/annals.1296.009 (2004).
40. Aguilera, G., Kiss, A. & Luo, X. Increased expression of type 1 angiotensin II receptors in the hypothalamic paraventricular nucleus following stress and glucocorticoid administration. J. Neuroendocrinol. 7, 775–783. https://doi.org/10.1111/j.1365-2826.1995.tb00714.x (1995).
41. Wang, L., Hiller, H., Smith, J. A., Kloet, A. D. & Krause, E. G. Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus control cardiovascular reactivity and anxiety-like behavior in male mice. Physiol. Genomics 48, 667–676. https:// doi.org/10.1152/physiolgenomics.00029.2016 (2016).
42. Sarkar, S., Fekete, C., Légrádi, G. & Lechan, R. M. Glucagon like peptide-1 (7–36) amide (GLP-1) nerve terminals densely inner- vate corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Brain Res. 985, 163–168. https://doi. org/10.1016/s0006-8993(03)03117-2 (2003).
43. Liu, J. et al. Enhanced AMPA receptor trafficking mediates the anorexigenic effect of endogenous glucagon-like peptide-1 in the paraventricular hypothalamus. Neuron 96, 897-909.e895. https://doi.org/10.1016/j.neuron.2017.09.042 (2017).
44. Katsurada, K. et al. Endogenous GLP-1 acts on paraventricular nucleus to suppress feeding: projection from nucleus tractus solitarius and activation of corticotropin-releasing hormone, nesfatin-1 and oxytocin neurons. Biochem. Biophys. Res. Commun. 451, 276–281. https://doi.org/10.1016/j.bbrc.2014.07.116 (2014).
45. Dimitrov, E. L., DeJoseph, M. R., Brownfield, M. S. & Urban, J. H. Involvement of neuropeptide Y Y1 receptors in the regulation of neuroendocrine corticotropin-releasing hormone neuronal activity. Endocrinology 148, 3666–3673. https://doi.org/10.1210/ en.2006-1730 (2007).
46. Zhang, J. & Rivest, S. Distribution, regulation and colocalization of the genes encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal responses to systemic inflammation. Eur. J. Neurosci. 11, 2651–2668. https://doi.org/10.104 6/j.1460-9568.1999.00682.x (1999).
47. Sunstrum, J. K. & Inoue, W. Heterosynaptic modulation in the paraventricular nucleus of the hypothalamus. Neuropharmacology 154, 87–95. https://doi.org/10.1016/j.neuropharm.2018.11.004 (2019).
48. Narahashi, T. Tetrodotoxin: a brief history. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 84, 147–154. https://doi.org/10.2183/pjab.84.147 (2008).
49. Lu, V. B., Ikeda, S. R. & Puhl, H. L. 3rd. A 3.7 kb fragment of the mouse Scn10a gene promoter directs neural crest but not placodal lineage EGFP expression in a transgenic animal. J. Neurosci. 35, 8021–8034. https://doi.org/10.1523/jneurosci.0214-15.2015 (2015).
50. Bünemann, M. & Hosey, M. M. G-protein coupled receptor kinases as modulators of G-protein signalling. J. Physiol. 517(Pt 1), 5–23. https://doi.org/10.1111/j.1469-7793.1999.0005z.x (1999).
51. Young, S. F., Griffante, C. & Aguilera, G. Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors. Cell. Mol. Neurobiol. 27, 439–461. https://doi.org/10.1007/s10571-006-9135-8 (2007).
52. Mikhailova, M. V. et al. Heterooligomerization between vasotocin and corticotropin-releasing hormone (CRH) receptors augments CRH-stimulated 3′,5′-cyclic adenosine monophosphate production. Mol. Endocrinol. 21, 2178–2188. https://doi.org/10.1210/ me.2007-0160 (2007).
53. Gilman, T. L., DaMert, J. P., Meduri, J. D. & Jasnow, A. M. Grin1 deletion in CRF neurons sex-dependently enhances fear, sociabil- ity, and social stress responsivity. Psychoneuroendocrinology 58, 33–45. https://doi.org/10.1016/j.psyneuen.2015.04.010 (2015).
54. Gafford, G., Jasnow, A. M. & Ressler, K. J. Grin1 receptor deletion within CRF neurons enhances fear memory. PLoS ONE 9, e111009. https://doi.org/10.1371/journal.pone.0111009 (2014).
55. Zaninetti, M., Tribollet, E., Bertrand, D. & Raggenbass, M. Nicotinic cholinergic activation of magnocellular neurons of the hypothalamic paraventricular nucleus. Neuroscience 110, 287–299. https://doi.org/10.1016/s0306-4522(01)00536-x (2002).
56. Grienberger, C. & Konnerth, A. Imaging calcium in neurons. Neuron 73, 862–885. https://doi.org/10.1016/j.neuron.2012.02.011 (2012).
57. Khan, A. M. et al. Catecholaminergic control of mitogen-activated protein kinase signaling in paraventricular neuroendocrine neurons in vivo and in vitro: a proposed role during glycemic challenges. J. Neurosci. 27, 7344–7360. https://doi.org/10.1523/jneur osci.0873-07.2007 (2007).
58. Wiegert, J. S. & Bading, H. Activity-dependent calcium signaling and ERK-MAP kinases in neurons: a link to structural plasticity of the nucleus and gene transcription regulation. Cell Calcium 49, 296–305. https://doi.org/10.1016/j.ceca.2010.11.009 (2011).
59. Milanick, W. J., Polo-Parada, L., Dantzler, H. A. & Kline, D. D. Activation of alpha-1 adrenergic receptors increases cytosolic calcium in neurones of the paraventricular nucleus of the hypothalamus. J. Neuroendocrinol. 31, e12791. https://doi.org/10.1111/ jne.12791 (2019).
60. Herman, J. P. Regulation of hypothalamo-pituitary-adrenocortical responses to stressors by the nucleus of the solitary tract/dorsal vagal complex. Cell. Mol. Neurobiol. 38, 25–35. https://doi.org/10.1007/s10571-017-0543-8 (2018).
61. Yamashita, H., Inenaga, K. & Dyball, R. E. Thermal, osmotic and chemical modulation of neural activity in the paraventricular nucleus: in vitro studies. Brain Res. Bull. 20, 825–829. https://doi.org/10.1016/0361-9230(88)90098-6 (1988).
62. Daftary, S. S., Boudaba, C. & Tasker, J. G. Noradrenergic regulation of parvocellular neurons in the rat hypothalamic paraventricular nucleus. Neuroscience 96, 743–751. https://doi.org/10.1016/s0306-4522(00)00003-8 (2000).
63. Lowe, D. G. Distinctive image features from scale-invariant keypoints. Int. J. Comput. Vis. 60, 91–110. https://doi.org/10.1023/ b:Visi.0000029664.99615.94 (2004).
64. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682. https://doi.org/10.1038/ nmeth.2019 (2012).